Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer
机构：[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[2]Department of Urology, The Third People's Hospital of Chengdu, Chengdu, China.
[This retracts the article DOI: 10.21037/atm-22-4318.].2023 Annals of Translational Medicine. All rights reserved.
语种：
外文
PubmedID：
第一作者：
第一作者机构：[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
推荐引用方式(GB/T 7714)：
Wang Zhipeng,Liu Haoyang,Zhao Jinge,et al.Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer[J].Annals of translational medicine.2023,11(9):332.doi:10.21037/atm-2023-7.
APA：
Wang Zhipeng,Liu Haoyang,Zhao Jinge,Chen Junru,Zhu Sha...&Zeng Hao.(2023).Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer.Annals of translational medicine,11,(9)
MLA：
Wang Zhipeng,et al."Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer".Annals of translational medicine 11..9(2023):332
